Diagnostic criteria for Hypertension

Reading Document
Medical Text Search

hypertension diagnostic criteria classification blood pressure thresholds

Medical Text Search

hypertension staging ACC AHA JNC guidelines measurement

GradeResponse
GradeResponse

Diagnostic Criteria for Hypertension


How Blood Pressure is Measured for Diagnosis

Hypertension diagnosis requires confirmation — a single elevated reading is not sufficient. The diagnosis must be confirmed using:
  • Out-of-office measurements (HBPM or ABPM), or
  • At least one additional subsequent office measurement
Three measurement modalities are used:
  • Office BP (OBP) — clinic/office sphygmomanometry
  • Home Blood Pressure Monitoring (HBPM) — patient self-measurement
  • Ambulatory Blood Pressure Monitoring (ABPM) — 24-hour automated recording

BP Classification Table

(ESC Guidelines — Management of Elevated Blood Pressure and Hypertension, p. 26)
CategoryOffice BPHBPMABPM (Daytime)
Non-ElevatedSBP <120 and DBP <70 mmHgSBP <120 and DBP <70 mmHgSBP <120 and DBP <70 mmHg
Elevated BPSBP 120–139 or DBP 70–89 mmHgSBP 120–134 or DBP 70–84 mmHgSBP 120–134 or DBP 70–84 mmHg
HypertensionSBP ≥140 or DBP ≥90 mmHgSBP ≥135 or DBP ≥85 mmHgSBP ≥135 or DBP ≥85 mmHg

ACC/AHA 2017 Classification (North American Standard)

(Harrison's Principles of Internal Medicine, 21st ed., p. 7682)
The 2017 ACC/AHA guidelines use a lower threshold for hypertension:
CategorySBPDBP
Normal<120 mmHg<80 mmHg
Elevated120–129 mmHg<80 mmHg
Stage 1 Hypertension130–139 mmHgor 80–89 mmHg
Stage 2 Hypertension≥140 mmHgor ≥90 mmHg
Hypertensive Crisis>180 mmHgand/or >120 mmHg
Key difference: ACC/AHA 2017 defines hypertension at ≥130/80 mmHg, while ESC and most international guidelines retain the traditional ≥140/90 mmHg office threshold.

Treatment Thresholds (ACC/AHA 2017)

  • High ASCVD risk patients (10-year risk ≥10%, CKD, diabetes): target <130/80 mmHg
  • Lower-risk patients: strongest clinical trial evidence supports target <140/90 mmHg
  • Age >80 years: individualized targets; aggressive lowering carries higher risk

Special Considerations

PhenotypeDefinitionClinical Significance
White Coat HypertensionElevated office BP, normal HBPM/ABPMRequires out-of-office confirmation before diagnosis
Masked HypertensionNormal office BP, elevated HBPM/ABPMHigher cardiovascular risk; detected by ABPM/HBPM
Isolated Systolic HTNSBP ≥140, DBP <90Common in elderly; independent CV risk factor
Hypertensive UrgencySBP >180 or DBP >120, no organ damageRequires prompt but not emergency BP reduction
Hypertensive EmergencySeverely elevated BP + acute target organ damageRequires ICU-level management

Key Diagnostic Principles

  1. Two or more readings on two or more occasions are needed before diagnosis
  2. Measure in both arms — use the arm with the higher reading
  3. Patient should be seated, rested ≥5 minutes, no caffeine/smoking for 30 minutes
  4. ABPM is the gold standard for confirming diagnosis and identifying white coat or masked hypertension
  5. Secondary causes should be excluded, especially in young patients, resistant hypertension, or sudden onset

Complications

Medical Text Search

hypertension complications target organ damage cardiovascular

Medical Text Search

hypertensive heart disease stroke renal failure complications

GradeResponse
GradeResponse

Complications of Hypertension

Hypertension causes target organ damage (TOD) — structural or functional injury to the heart, vasculature, kidneys, brain, and retina. More than 50% of hypertensive individuals have at least one form of TOD, and the number of affected organs directly correlates with cardiovascular risk. (ACC/AHA Guidelines, p. 49; Harrison's 21st ed., p. 7631)

1. Cardiac Complications

ComplicationMechanismFeatures
Left Ventricular Hypertrophy (LVH)Chronic pressure overload → myocardial remodelingConcentric or eccentric; detected on ECG/Echo
Heart Failure (HF)LVH → diastolic dysfunction → systolic failureHFpEF more common initially; HFrEF in late stages
Coronary Heart Disease (CHD)Accelerated atherosclerosisAngina, MI; HTN doubles CHD risk
Atrial FibrillationLA enlargement from elevated filling pressuresMajor risk factor for cardioembolic stroke

2. Cerebrovascular Complications

ComplicationNotes
Ischemic StrokeMost common stroke type; HTN is the single greatest modifiable risk factor
Hemorrhagic StrokeDue to rupture of small penetrating arteries (Charcot-Bouchard aneurysms)
Hypertensive EncephalopathyBreakthrough hyperperfusion → cerebral edema; headache, confusion, seizures
Vascular DementiaChronic small vessel disease → lacunar infarcts, white matter changes
Lacunar InfarctsSmall deep infarcts from lipohyalinosis of perforating arteries

3. Renal Complications

ComplicationMechanism
Hypertensive NephrosclerosisAfferent arteriolar sclerosis → ischemic glomerular injury → CKD
Proteinuria / AlbuminuriaEarly marker of glomerular damage; independent CV risk factor
Chronic Kidney Disease (CKD)Reduced eGFR; HTN is a leading cause of end-stage renal disease (ESRD)
Renal Artery StenosisCan both cause and be worsened by hypertension (renovascular HTN)

4. Vascular Complications

ComplicationNotes
Peripheral Arterial Disease (PAD)Accelerated atherosclerosis in lower limb vessels; claudication, critical limb ischemia
Aortic AneurysmEspecially thoracic and abdominal aortic aneurysms
Aortic DissectionAcute HTN is the most common precipitant
Accelerated AtherosclerosisSystemic endothelial injury across all vascular beds

5. Retinal Complications (Hypertensive Retinopathy)

Graded by the Keith-Wagener-Barker (KWB) classification:
GradeFindings
IMild arteriolar narrowing, increased arteriovenous (AV) ratio
IIDefinite arteriolar narrowing + AV nicking (Gunn's sign)
IIIFlame hemorrhages, cotton wool spots, hard exudates
IVGrade III + papilledema (hypertensive emergency)

6. Hypertensive Emergencies (Acute Severe Complications)

These occur when severely elevated BP (typically >180/120 mmHg) causes acute target organ damage:
  • Hypertensive encephalopathy
  • Acute pulmonary edema / flash pulmonary edema
  • Acute MI or unstable angina
  • Acute aortic dissection
  • Acute kidney injury (AKI)
  • Eclampsia (in pregnancy)

Summary: Organ-wise Complication Overview

Hypertension
├── Heart → LVH, HF, CHD, AF
├── Brain → Stroke (ischemic/hemorrhagic), dementia, encephalopathy
├── Kidneys → CKD, proteinuria, ESRD
├── Vessels → PAD, aortic aneurysm, dissection
└── Eyes → Hypertensive retinopathy (Grades I–IV)
Hypertension doubles the risk of coronary heart disease, congestive heart failure, ischemic and hemorrhagic stroke, renal failure, and peripheral arterial disease. (Harrison's 21st ed., p. 7631)

Diagnostic methods

Medical Text Search

hypertension diagnostic methods investigation workup laboratory ECG

Medical Text Search

ambulatory blood pressure monitoring ABPM HBPM white coat hypertension diagnosis

GradeResponse
GradeResponse
Medical Text Search

hypertension evaluation secondary causes echocardiogram renal imaging workup

Diagnostic Methods for Hypertension

Diagnosis involves three pillars: accurate BP measurement, identifying secondary causes, and assessing target organ damage.

1. Blood Pressure Measurement Techniques

A. Office / Clinic BP (OBP)

  • Patient seated, rested ≥5 minutes; no caffeine/smoking for 30 minutes
  • Arm supported at heart level; appropriate cuff size mandatory
  • Average of ≥2 readings on ≥2 separate visits
  • Measure both arms — use the higher reading arm consistently
  • Check standing BP in elderly/diabetics to detect orthostatic hypotension

B. Ambulatory Blood Pressure Monitoring (ABPM) — Gold Standard

  • 24-hour automated readings every 15–30 minutes (day and night)
  • Best for diagnosing white coat and masked hypertension
  • Provides nocturnal dipping data (non-dipping pattern = higher CV risk)
  • Recommended by VA/DoD, USPSTF 2015, and AHA/ACC 2017 to confirm diagnosis before initiating drug therapy (Diagnosis and Management of HTN in Primary Care, p. 31)
ABPM PatternDefinitionSignificance
White Coat HTNElevated office BP, normal ABPMAvoid unnecessary drug therapy
Masked HTNNormal office BP, elevated ABPMHigher CV risk; often undertreated
Sustained HTNElevated in bothHighest risk; treat promptly
Non-dipper<10% nocturnal BP fallAssociated with increased organ damage

C. Home Blood Pressure Monitoring (HBPM)

  • Patient self-measures morning and evening over 7 days
  • Average of readings (discarding day 1) used for diagnosis
  • More accessible than ABPM; requires patient training
  • Useful for detecting masked HTN and monitoring treatment response

2. Routine Laboratory Investigations

These assess cardiovascular risk factors and identify target organ damage or secondary causes:
TestPurpose
Urinalysis + urine albumin:creatinine ratioDetect proteinuria/albuminuria (renal TOD)
Serum creatinine + eGFRRenal function; detect CKD
Serum electrolytes (Na⁺, K⁺)Hypokalemia → suspect primary aldosteronism
Fasting blood glucose / HbA1cDiabetes co-assessment
Fasting lipid profileTotal CV risk stratification
Complete blood count (CBC)Anemia, polycythemia
Thyroid function tests (TSH)Hypothyroidism/hyperthyroidism as secondary cause
Serum uric acidGout risk; elevated in metabolic syndrome

3. Electrocardiogram (ECG)

  • First-line cardiac investigation in all hypertensive patients
  • Detects Left Ventricular Hypertrophy (LVH):
    • Sokolow-Lyon criteria: S in V1 + R in V5/V6 >35 mm
    • Cornell criteria: R in aVL + S in V3 >28 mm (men) / >20 mm (women)
  • ST depression and T-wave inversion = LV strain pattern (advanced hypertensive heart disease)
  • Detects arrhythmias (e.g., atrial fibrillation), conduction defects, prior MI

4. Echocardiography

  • Detects LVH more sensitively than ECG
  • Assesses left ventricular mass index (LVMI), geometry (concentric vs. eccentric)
  • Evaluates diastolic dysfunction (early hypertensive heart disease)
  • Measures ejection fraction; detects valvular disease
  • Indicated when ECG is abnormal or symptoms of HF are present

5. Imaging Studies

InvestigationIndication
Renal ultrasoundAssess kidney size, echogenicity; detect renal artery stenosis
Renal Doppler ultrasoundRenovascular hypertension screening
MR/CT angiographyConfirm renal artery stenosis, aortic coarctation
Adrenal CT/MRISuspected pheochromocytoma or Conn's adenoma
Chest X-rayCardiomegaly, pulmonary congestion, aortic knuckle
FundoscopyHypertensive retinopathy grading (KWB Grade I–IV)

6. Investigations for Secondary Hypertension

Suspect secondary HTN in: young patients, resistant HTN, sudden onset, severe/uncontrolled despite triple therapy, hypokalemia, or features of an underlying cause.
Suspected CauseScreening TestConfirmatory Test
Primary AldosteronismAldosterone:renin ratio (ARR)Fludrocortisone suppression test; adrenal CT
Renovascular HTNRenal Doppler ultrasoundCT/MR angiography
Pheochromocytoma24h urinary metanephrines or plasma metanephrinesAdrenal CT/MRI; MIBG scan
Cushing's Syndrome24h urinary cortisol; overnight dexamethasone suppression testLow-dose DST; CRH stimulation test
Hypothyroidism / HyperthyroidismTSHFree T4, T3
Obstructive Sleep ApneaEpworth sleepiness scale; SpO₂ monitoringPolysomnography
Coarctation of AortaBP differential arms vs. legs; CXR (rib notching)CT/MR aortography

Diagnostic Approach Summary

Elevated Office BP (≥140/90 mmHg)
        ↓
Confirm with ABPM or HBPM
        ↓
Routine labs + ECG + fundoscopy
        ↓
Assess target organ damage (Echo, renal function, urine albumin)
        ↓
Screen for secondary causes if clinically indicated
        ↓
Cardiovascular risk stratification → guide treatment threshold

Difference between hypertension and hypertonia

These are two entirely distinct medical terms that are frequently confused due to their similar roots.

Hypertension vs. Hypertonia

FeatureHypertensionHypertonia
DefinitionPersistently elevated blood pressure in the arterial systemAbnormally increased muscle tone (resistance to passive stretch)
System involvedCardiovascular systemNeuromuscular system
Primary concernVascular/hemodynamicNeurological/musculoskeletal
Measured bySphygmomanometer (mmHg)Clinical examination (passive range of motion)

Hypertension

  • Elevation of systemic arterial BP (≥140/90 mmHg by ESC; ≥130/80 mmHg by ACC/AHA)
  • Caused by increased cardiac output, increased peripheral vascular resistance, or both
  • Complications: stroke, MI, heart failure, CKD, retinopathy (as covered above)

Hypertonia

  • Increased resistance to passive movement of a muscle or limb
  • Results from upper motor neuron (UMN) lesions disrupting descending inhibitory pathways
  • Two main subtypes:
TypeMechanismCharacterAssociated Conditions
SpasticityUMN lesion (corticospinal tract)Velocity-dependent; "clasp-knife" phenomenonStroke, MS, cerebral palsy, spinal cord injury
RigidityBasal ganglia dysfunctionVelocity-independent; "lead-pipe" or "cogwheel" (with tremor)Parkinson's disease, parkinsonian syndromes

The "Hyper-" Confusion — Quick Reference

TermMeaning
HypertensionHigh blood pressure
HypertoniaHigh muscle tone
HypertrophyIncrease in cell/organ size
HypertonicityHigh osmolarity of a solution (also used loosely for hypertonia)

In short: Hypertension is a cardiovascular condition; hypertonia is a neurological one. They share a Greek prefix (hyper- = excessive) but refer to completely different physiological systems.
This is a shared conversation. Sign in to Orris to start your own chat.